Home › Regeneron Pharms Receives Neutral Rating from Zacks
 

Keywords :   


Regeneron Pharms Receives Neutral Rating from Zacks

2013-02-19 04:07:39| Biotech - Topix.net

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.

Tags: rating receives neutral zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »